These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 18186308)
1. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation. Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308 [TBL] [Abstract][Full Text] [Related]
2. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation. Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753 [TBL] [Abstract][Full Text] [Related]
3. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart. Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249 [TBL] [Abstract][Full Text] [Related]
4. [Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration]. Komatsu T; Nakamura S; Suzuki O; Horiuchi D; Owada S; Kameda K; Tomita H; Oikawa K; Abe N; Okumura K J Cardiol; 2003 Feb; 41(2):73-80. PubMed ID: 12649925 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial. Yamase M; Nakazato Y; Daida H Heart; 2012 Jul; 98(14):1067-71. PubMed ID: 22689712 [TBL] [Abstract][Full Text] [Related]
6. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation. Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817 [TBL] [Abstract][Full Text] [Related]
7. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study. Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131 [TBL] [Abstract][Full Text] [Related]
8. Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation. Lan X; Su L; Ling Z; Liu Z; Wu J; Yang X; Zrenner B; Yin Y Eur J Clin Invest; 2009 Aug; 39(8):657-63. PubMed ID: 19490069 [TBL] [Abstract][Full Text] [Related]
9. [Long-term clinical efficacy of losartan or perindopril combination therapy with low-dose amiodarone in patients with paroxysmal atrial fibrillation]. Yin YH; Liu ZC; Wu JJ; Dai Y; Su L; Lan XB; Ling ZY; Yang XY; Luo KL Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):299-302. PubMed ID: 16776916 [TBL] [Abstract][Full Text] [Related]
10. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study]. Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720 [TBL] [Abstract][Full Text] [Related]
11. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228 [TBL] [Abstract][Full Text] [Related]
12. Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation. Kawamura M; Ito H; Onuki T; Miyoshi F; Watanabe N; Asano T; Tanno K; Kobayashi Y J Cardiovasc Pharmacol; 2010 May; 55(5):511-7. PubMed ID: 20164787 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation. Lip GY; Frison L; Grind M J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713 [TBL] [Abstract][Full Text] [Related]
14. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation. Ducharme A; Schiffrin EL Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287 [TBL] [Abstract][Full Text] [Related]
15. [Effect of surgical treatment of atrial fibrillation on the attainment and maintenance of sinus rhythm in patients undergoing concomitant cardiac surgery--short-term results]. Kolek M; Brát R Cas Lek Cesk; 2007; 146(4):383-92; discussion 392-5. PubMed ID: 17491249 [TBL] [Abstract][Full Text] [Related]
16. Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy. Kawamura M; Munetsugu Y; Tanno K; Kobayashi Y J Cardiovasc Pharmacol; 2013 Jan; 61(1):77-82. PubMed ID: 23107870 [TBL] [Abstract][Full Text] [Related]
17. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction. Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613 [TBL] [Abstract][Full Text] [Related]
18. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation. Fujiki A; Tsuneda T; Sakabe M; Nakagawa K; Mizumaki K; Hirai T; Inoue H Circ J; 2004 Sep; 68(9):834-9. PubMed ID: 15329504 [TBL] [Abstract][Full Text] [Related]
19. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation]. Doğan A; Akçay S Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening? Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]